CLINICAL SCIENCE
Treatment with dasatinib or nilotinib in chronic myeloid leukemia patients who failed to respond to two previously administered tyrosine kinase inhibitors – a single center experience
Beatriz Felicio Ribeiro, Eliana C M Miranda, Dulcinéia Martins de Albuquerque, Márcia T Delamain, Gislaine Oliveira-Duarte, Maria Helena Almeida, Bruna Vergílio, Rosana Antunes da Silveira, Vagner Oliveira-Duarte, Irene Lorand-Metze, Carmino A De Souza, Katia B B Pagnano
Corresponding author
Universidade de Campinas (Unicamp), Centro de Hematologia e Hemoterapia Campinas/SP, Brazil
Read
962
Timeswas read the article
247
Total PDF
715
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 July | 7 | 9 | 16 |
| 2024 June | 46 | 24 | 70 |
| 2024 May | 40 | 24 | 64 |
| 2024 April | 41 | 20 | 61 |
| 2024 March | 65 | 19 | 84 |
| 2024 February | 63 | 15 | 78 |
| 2024 January | 84 | 13 | 97 |
| 2023 December | 41 | 16 | 57 |
| 2023 November | 45 | 28 | 73 |
| 2023 October | 44 | 18 | 62 |
| 2023 September | 27 | 16 | 43 |
| 2023 August | 15 | 1 | 16 |
| 2023 July | 23 | 13 | 36 |
| 2023 June | 24 | 6 | 30 |
| 2023 May | 41 | 2 | 43 |
| 2023 April | 39 | 1 | 40 |
| 2023 March | 34 | 1 | 35 |
| 2023 February | 14 | 3 | 17 |
| 2023 January | 16 | 7 | 23 |
| 2022 December | 6 | 11 | 17 |
Show all